WO2008059197A3 - Topical composition comprising an anti- inflammatory steroid and a non-steroidal anti -inflammatory drug - Google Patents
Topical composition comprising an anti- inflammatory steroid and a non-steroidal anti -inflammatory drug Download PDFInfo
- Publication number
- WO2008059197A3 WO2008059197A3 PCT/GB2007/004042 GB2007004042W WO2008059197A3 WO 2008059197 A3 WO2008059197 A3 WO 2008059197A3 GB 2007004042 W GB2007004042 W GB 2007004042W WO 2008059197 A3 WO2008059197 A3 WO 2008059197A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- inflammatory
- topical composition
- steroid
- steroidal anti
- medicament
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Abstract
Use of an anti-inflammatory steroid and a non-steroidal anti-inflammatory drug in the manufacture of a medicament for topical application to a joint of a patient. The medicament may be for treating pain and inflammation at said joint and may be for treating inflammatory arthritis, osteoarthritis or rheumatoid arthritis at said joint. The medicament may be in the form of a transdermal patch.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0622920.7A GB0622920D0 (en) | 2006-11-17 | 2006-11-17 | Topical treatment |
GB0622920.7 | 2006-11-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008059197A2 WO2008059197A2 (en) | 2008-05-22 |
WO2008059197A3 true WO2008059197A3 (en) | 2008-07-17 |
Family
ID=37605447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2007/004042 WO2008059197A2 (en) | 2006-11-17 | 2007-10-24 | Topical composition comprising an anti- inflammatory steroid and a non-steroidal anti -inflammatory drug |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0622920D0 (en) |
WO (1) | WO2008059197A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0915319D0 (en) * | 2009-09-03 | 2009-10-07 | Sharma Anant | Combination medicament |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4185100A (en) * | 1976-05-13 | 1980-01-22 | Johnson & Johnson | Topical anti-inflammatory drug therapy |
US5741510A (en) * | 1994-03-30 | 1998-04-21 | Lectec Corporation | Adhesive patch for applying analgesic medication to the skin |
US6193996B1 (en) * | 1998-04-02 | 2001-02-27 | 3M Innovative Properties Company | Device for the transdermal delivery of diclofenac |
US6335034B1 (en) * | 1995-09-29 | 2002-01-01 | L.A.M. Pharmaceutical Corporation | Topical drug preparations |
US6423697B1 (en) * | 1999-01-14 | 2002-07-23 | Mark Friedman | Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache, facial pain, and cervical-muscle spasm |
US20050276842A1 (en) * | 2004-06-07 | 2005-12-15 | Zars, Inc. | Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same |
US20060223788A1 (en) * | 2005-03-29 | 2006-10-05 | Cathcart Clifton H | Analgesic composition for topical use |
-
2006
- 2006-11-17 GB GBGB0622920.7A patent/GB0622920D0/en not_active Ceased
-
2007
- 2007-10-24 WO PCT/GB2007/004042 patent/WO2008059197A2/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4185100A (en) * | 1976-05-13 | 1980-01-22 | Johnson & Johnson | Topical anti-inflammatory drug therapy |
US5741510A (en) * | 1994-03-30 | 1998-04-21 | Lectec Corporation | Adhesive patch for applying analgesic medication to the skin |
US6335034B1 (en) * | 1995-09-29 | 2002-01-01 | L.A.M. Pharmaceutical Corporation | Topical drug preparations |
US6193996B1 (en) * | 1998-04-02 | 2001-02-27 | 3M Innovative Properties Company | Device for the transdermal delivery of diclofenac |
US6423697B1 (en) * | 1999-01-14 | 2002-07-23 | Mark Friedman | Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache, facial pain, and cervical-muscle spasm |
US20050276842A1 (en) * | 2004-06-07 | 2005-12-15 | Zars, Inc. | Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same |
US20060223788A1 (en) * | 2005-03-29 | 2006-10-05 | Cathcart Clifton H | Analgesic composition for topical use |
Non-Patent Citations (4)
Title |
---|
BUCCI F A ET AL: "Comparison of ketorolac 0.5%, ketorolac 0.4%, and diclofenac 0.1% on Aqueous Flare Following Cataract Surgery", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, OPHTHALMOLOGY, HAGERSTOWN, MD, vol. 46, no. Suppl. S, 1 January 2005 (2005-01-01), pages 789, XP008091674, ISSN: 0146-0404 * |
LEWIS A J: "THE LOCAL ANTI-INFLAMMATORY ACTIVITY OF RIMEXOLONE (ORG 6216) IN FIBRIN-INDUCED MONOARTICULAR ARTHRITIS AND ADJUVANT-INDUCED ARTHRITIS", AGENTS AND ACTIONS, BIRKHAEUSER VERLAG, BASEL, CH, vol. 10, no. 3, 1 January 1980 (1980-01-01), pages 258 - 265, XP009008537, ISSN: 0065-4299 * |
MATTEUCCI PAOLA ET AL: "Topical prophylaxis of conjunctivitis induced by high-dose cytosine arabinoside", HAEMATOLOGICA, FONDAZIONE FERRATA STORTI, ROME, IT, vol. 91, no. 2, 1 February 2006 (2006-02-01), pages 255 - 257, XP008091676, ISSN: 0390-6078 * |
ROBECCHI A ET AL: "Combination of prednisooe and indomethadn in the treatment of rheumatoid arthritis", REUMATISMO, LONGANESI, MILAN, IT, vol. 18, no. 6, 1 January 1964 (1964-01-01), pages 388 - 392, XP008091663, ISSN: 0048-7449 * |
Also Published As
Publication number | Publication date |
---|---|
GB0622920D0 (en) | 2006-12-27 |
WO2008059197A2 (en) | 2008-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009129149A3 (en) | Drug depots having different release profiles for reducing, preventing or treating pain and inflammation | |
WO2011016881A3 (en) | An implantable drug depot having a reversible phase transition material for treatment of pain and/or inflammation | |
WO2009129147A3 (en) | Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation | |
WO2008157103A3 (en) | Modified release solid or semi-solid dosage forms | |
IL194184A0 (en) | Formulations of low dose non-steroidal anti-inflammatory drugs and beta-cyclodextrin | |
WO2010011526A3 (en) | Drug depots having one or more anchoring members | |
WO2008089307A3 (en) | Delta 5 desaturase inhibitors for the treatment of pain, inflammation and cancer | |
WO2007093183A3 (en) | Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases | |
WO2010070675A8 (en) | Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof | |
EP2318033B8 (en) | Compositions for the treatment of pain and/or inflammation | |
WO2006100213A8 (en) | Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a cox-2 inhibitor | |
WO2009063378A3 (en) | Olive oil formulation for pain relief | |
WO2007112453A3 (en) | Methods amd compositions for treating conditions | |
WO2008012796A3 (en) | Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation | |
WO2007100561A3 (en) | Use of dha and ara in the preparation of a composition for preventing or treating obesity | |
WO2012019188A3 (en) | Methods and compositions for the inhibition of fructokinase | |
WO2011074015A3 (en) | Composition of pharmaceutical product to treat sexual dysfunction | |
EP1844779A3 (en) | Tergurid/protergurid for treating chronic pain (e.g. migraine) | |
WO2009012472A3 (en) | Methods and compositions for treating conditions | |
WO2008059197A3 (en) | Topical composition comprising an anti- inflammatory steroid and a non-steroidal anti -inflammatory drug | |
MX2010004513A (en) | A standardized plant extract, process for obtaining the same and uses thereof. | |
ATE505477T1 (en) | AMORPHOUS FORM OF (11BETA,16ALPHA)-9-FLUORO-11- | |
WO2010007494A3 (en) | New composition for the treatment of ecchymotic pigmentations | |
WO2008084171A3 (en) | Use of nepafenac or derivatives thereof for treating dermatological disorders linked with a keratinisation disorder that may include an inflammatory immuno-allergic component | |
WO2007112968A3 (en) | Anti-inflammatory polymer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07824290 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07824290 Country of ref document: EP Kind code of ref document: A2 |